Table 1:
Patient characteristics | Patients receiving anti-aggregation (n = 38) | Propensity score-matched patients not receiving antiplatelet therapy (n = 141) | P |
---|---|---|---|
Age, years (mean) ± SD (range) | 68 ± 5 (47–81) | 67 ± 8 (49–71) | 1.00 |
Male, n (%) | 21 (55) | 103 (73) | |
Female, n (%) | 17 (45) | 40 (28) | |
History of myocardial infarction, CABG and/or valve placement, n (%) | 19 (50) | 78 (55) | 0.6963 |
Presence of a coronary stent, n (%) | 11 (29) | 42 (30) | 1.00 |
History of severe peripheral vascular disease, n (%) | 8 (21) | 17 (12) | 0.1673 |
Patient on dual APT | 9 (24%) | 0 | |
Patient taking aspirin | 17 (45%) | 0 | |
Patient taking Clopidrogel | 12 (31%) | 0 |